Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose |
BNF code | 1404000H0AAAJAJ |
Virtual Therapeutic Moiety | Influenza vaccine |
Abbreviated name | Influenza vacc (live attenuated) nsl susp 0.2ml unit dose |
Basis of preferred name | Other |
Date of name applicability | 21 Dec 2011 |
Previous name | Influenza vaccine (live attenuated) nasal spray |
Basis of previous name | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 0.200 |
Unit dose form units | ml |
Unit dose unit of measure | unit dose |
Virtual Product Ingredient | |
---|---|
Ingredient | Influenza virus live attenuated |
Ontology Drug Form & Route | |
Form & Route | suspensionspray.nasal |
Dose Form | |
Formulation | Spray |
Drug Route | |
Route | Nasal |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Fluenz Tetra vaccine nasal suspension 0.2ml unit dose (AstraZeneca UK Ltd) | |
Virtual Medicinal Product Packs | |
Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose 10 unit dose |
dm+d data retrieved from TRUD: release NHSBSA_6.0.0_20240603000001, imported on 3rd June 2024 at 04:58:20.